Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonia Cohen

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|May 31, 2020
Mixed Response to Immunotherapy in Patients with Metastatic MelanomaDaan Jan Willem Rauwerdink, George Molina, Dennie Tompers Frederick, et al.
Annals of Surgical Oncology|December 29, 2023
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II MelanomaAikaterini Dedeilia, Thinzar Lwin, Siming Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 28, 2014
MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticityJie V Deng, Yehong Wan, Xiaoting Wang, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
The anti-virus T cell response dominates the anti-cancer response in oncolytic virus therapyMeghan J O'Melia, Kailan Sierra-Davidson, Miranda A Robert, et al.
JAMA Dermatology|April 15, 2026
Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic MelanomaJordan T Said, Yunxi Li, Nakisa Sadeghi, et al.
Journal of Surgical Oncology|June 17, 2024
Factors associated with skeletal-related events in patients with bone metastatic melanoma: A retrospective study of 481 patientsMichelle R Shimizu, Tom M de Groot, Peter K Twining, et al.
Nature|June 18, 2013
Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoRDaniel H Ebert, Harrison W Gabel, Nathaniel D Robinson, et al.
JCI Insight|April 9, 2026
Loss of Tumor-Infiltrating Lymphocytes and Poor Response to Immunotherapy in IDH GOF Mutant MelanomaEmma Specht, Lakshmi Pakanati, Meng-Ju Wu, et al.
Neuron|January 31, 2012
Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assemblySarah E Ross, Alejandra E McCord, Cynthia Jung, et al.
Molecular Therapy. Oncology|March 4, 2025
Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockadeAna Carolina M Domingues, Soraia B de Oliveira, Nayara G Tessarollo, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|May 31, 2020
Mixed Response to Immunotherapy in Patients with Metastatic MelanomaDaan Jan Willem Rauwerdink, George Molina, Dennie Tompers Frederick, et al.
Annals of Surgical Oncology|December 29, 2023
Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II MelanomaAikaterini Dedeilia, Thinzar Lwin, Siming Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 28, 2014
MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticityJie V Deng, Yehong Wan, Xiaoting Wang, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
The anti-virus T cell response dominates the anti-cancer response in oncolytic virus therapyMeghan J O'Melia, Kailan Sierra-Davidson, Miranda A Robert, et al.
JAMA Dermatology|April 15, 2026
Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic MelanomaJordan T Said, Yunxi Li, Nakisa Sadeghi, et al.
Journal of Surgical Oncology|June 17, 2024
Factors associated with skeletal-related events in patients with bone metastatic melanoma: A retrospective study of 481 patientsMichelle R Shimizu, Tom M de Groot, Peter K Twining, et al.
Nature|June 18, 2013
Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoRDaniel H Ebert, Harrison W Gabel, Nathaniel D Robinson, et al.
JCI Insight|April 9, 2026
Loss of Tumor-Infiltrating Lymphocytes and Poor Response to Immunotherapy in IDH GOF Mutant MelanomaEmma Specht, Lakshmi Pakanati, Meng-Ju Wu, et al.
Neuron|January 31, 2012
Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assemblySarah E Ross, Alejandra E McCord, Cynthia Jung, et al.
Molecular Therapy. Oncology|March 4, 2025
Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockadeAna Carolina M Domingues, Soraia B de Oliveira, Nayara G Tessarollo, et al.
Pageof 6